TOPIC:

You're right, genetics play a role. The study of genetics combined with external factors, is called Epigenetics. This involves the study of external factors and how they play a role in switching genes on and off which can trigger various disorders.

I also agree about the chronic disease in children. Somehow, it has become normal and acceptable for children to be chronically ill. GMO's and vaccines play a role in this. To deny that vaccines contribute when these various disorders are listed on the vaccine package inserts is ridiculous. The US also has a very high infant mortality rate, higher than many other countries. We are trying to protect children from a few innocuous infectious diseases but causing even worse chronic illness. It makes no sense to place such emphasis on a handful of diseases and consider them deadly epidemics when there are worse infectious diseases with no vaccine and children are not dying from epidemics from those illnesses.

Sandi wrote:

You're right, genetics play a role. The study of genetics combined with external factors, is called Epigenetics. This involves the study of external factors and how they play a role in switching genes on and off which can trigger various disorders.

Some of the more fascinating studies are with identical twins where one gets something like autism, and the other does not.

I've heard a bit about epigenetics. It sounds promising, but apparently is in its infancy. Seems like most people were looking for silver bullets... one gene to point to and say Aha! That one is causing this type of cancer, or this autoimmune condition. Some of the research I've heard about is starting to looking at multiple genes influencing the disorder, which is not remotely surprising!

I've seen studies with twins also. It is interesting. Most of the things I saw had rats as subjects and they could actually manipulate the environmental factors in predisposed rats to cause the genetic condition to flare up while keeping another predisposed rat perfectly healthy. It doesn't take much to change things on a cellular level.

www.youtube.com/watch?v=-aHRMjVHggI
Says video restricted? It will not let me watch it. I must be doing something wrong. Any idea? Thanks

It started right up for me. All I did was click on the link.

Try going to Youtube and typing in "The Exploding Autoimmune Epidemic". Dr. Tent should be in the title.

EXCELLENT explanation of herd immunity. It's worth the 13 minutes to watch it.

www.facebook.com/614072562058406/videos/1135450243253966/?hc_ref=ARQEh_Tk5PBJls6UKXhp-6sLyI_kL0WNBg7Wo0LySlGPEW1vxvBHcjQ6J9pNXSArs9Q

"Since the implementation of the mass vaccination campaign against hepatitis B in France, the appearance of multiple sclerosis, sometimes occurring in the aftermath of vaccinations, led to the publication of epidemiological international studies. This was also justified by the sharp increase in the annual incidence of multiple sclerosis reported to the French health insurance in the mid-1990s. Almost 20 years later, a retrospective reflection can be sketched from these official data and also from the national pharmacovigilance agency. Statistical data from these latter sources seem to show a significant correlation between the number of hepatitis B vaccinations performed and the declaration to the pharmacovigilance of multiple sclerosis occurring between 1 and 2 years later. The application of the Hill’s criteria to these data indicates that the correlation between hepatitis B vaccine and multiple sclerosis may be causal."
More at:
www.ncbi.nlm.nih.gov/pmc/articles/PMC4266455/

"In May 2018, the Cochrane Collaboration published its review of the human papillomavirus (HPV) vaccines.1 The review primarily assessed the vaccines’ effect on precursors to cervical cancer. Cochrane has high standards for its reviews2; however, there were important limitations in its HPV vaccine review, which we address in this paper.

No included trial in the Cochrane review used a placebo comparator

All 26 trials included in the Cochrane review used active comparators: adjuvants (aluminium hydroxide (Al[OH]3) or amorphous aluminium hydroxyphosphate sulfate [AAHS]) or hepatitis vaccines.

Adjuvants are not regulated separately from their vaccine antigens. According to the Food and Drug Administration (FDA), adjuvants are unreliable comparators.7 One HPV vaccine manufacturer (GlaxoSmithKline that produces Cervarix) states that its aluminium-based comparator induces harms: ‘higher incidences of myalgia might namely be attributable to the higher content of aluminium in the HPV vaccine (450 μg Al[OH]3) than the content of aluminium in the HAV [hepatitis A] vaccine (225 μg Al[OH]3)’.8 The comparator hepatitis vaccines also used the HPV vaccines’ aluminium-based adjuvant.

The Cochrane authors mistakenly used the term placebo to describe the active comparators. They acknowledged that ‘The comparison of the risks of adverse events was compromised by the use of different products (adjuvants and hepatitis vaccines) administered to participants in the control group’. Nevertheless, this statement can easily be overlooked, as it comes after 7500 words about other issues in the discussion and under the heading ‘Potential biases in the review process’. Active comparators was not a bias in the review process but a bias in the design of the HPV vaccine trials.

The use of active comparators probably increased the occurrence of harms in the comparator groups and thereby masked harms caused by the HPV vaccines. It is noteworthy that many women were excluded from the trials if they had received the adjuvants before or had a history of immunological or nervous system disorders; for example, in the PATRICIA trial with 18 644 women9 and the FUTURE II trial with 12 167 women.10 These exclusion criteria lowered the external validity of the trials and suggest that the vaccine manufacturers were worried about harms caused by the adjuvants. The criteria are not listed as warnings on the package inserts of the HPV vaccines,11–13 which may have led to more vaccine-related harms in clinical practice than in the trials."

ebm.bmj.com/content/early/2018/07/27/bmjebm-2018-111012

Hi Sandi,
That was an amzing video. I learned a lot. I must say that I am at 260,000 platelets holding strong, g-d willing since 10/17/17 when I had my last IVIG. It was one month after I did the parasite cleanse and started homeopathic meds including virus, bacteria and fungus homeopathics, To refresh your memory, I caught some bug in Costa Rica 4/17 and Western medicine drs. had only IVIG, Promacta, NPlate, Dex bursts, Prednisone and Rituxin for me for 6 months. None of which was my cure, just a bandaid. And every 2 weeks I was needing IVIG, etc for as low as 1,000 platelet count. I had to get to the root of the issue...virus, parasites, bacteria and fungus! Once I got treated for the stuff I contacted in Costa Rica, I became fine. I am thankful someone has made an impactful video; thanks for sharing! I know everyone is different but the more people we can get well by helping them to understand to look for the underlying cause that Western doctors don't understand, the better!!! Thanks, Cindy

Great news, Cindy! I'm glad your counts are up and you're doing well. I love success stories! I agree, western medicine doesn't look for causes, they just diagnose and treat.

This article is well worth reading if you can get past the name of the actual website. I have provided links from highly credible studies below. Critical thinking is key. None of this is rare: it is simply denied and goes unrecognized. I'm a researcher and this is where it has led me. It is not hard to understand why or how this happens; the reasoning is quite simple. Autoimmunity is simply 'intolerance to 'self'' and if a body can reject it's own cells/tissues, then certainly it can go on a full scale attack on unknown foreign substances, causing inflammation and damage along the way.

"In 2011, Israeli physician and immune researcher Yehuda Shoenfeld proposed a new umbrella term for all of the diverse immune reactions to foreign substances—or adjuvants—in the body. He called it ASIA, and it is now sometimes called Shoenfeld's syndrome.
Shoenfeld is the founder of the Zabludowicz Center for Autoimmune Diseases at the Sheba Medical Center in Tel Aviv. In his more than four decades practicing immunology, he has authored or edited 35 textbooks on the immune system and published more than 1,850 research papers in medical journals.
The adjuvants Shoenfeld refers to in ASIA syndrome are substances or toxins capable of whipping the immune system into action. The persistent presence of these materials in some individuals provokes vague and sundry symptoms—chronic fatigue, muscle and joint pain, sleep disturbances, cognitive impairment, skin rashes and more—though Shoenfeld recognizes that they share the common underlying trigger of certain immune signaling pathways. Sometimes this low-grade inflammation can smolder for years only to suddenly incite an overt autoimmune disease.
In one full-day session, Abdullah Watad, a resident physician at Sheba Medical Center in Tel Aviv, explained that many vaccines including the human papilloma virus (HPV) vaccine and the hepatitis B (Hep vaccine contain aluminum because of its natural ability to jump-start the immune system into action against a vaccine virus. When the practice began in the 1920s, there was no understanding of how this vaccine adjuvant worked or if it was safe—only that it did the job.
Now a well-documented neurotoxin, aluminum is known to trigger a storm of unseen immune warfare—recruiting immune system combatants like macrophages, stimulating the production of cells such as neutrophils, and increasing the secretion of inflammatory cytokines like interleukins that signal other players to swing into motion, igniting domino effects that are poorly understood but differ from natural infection."

www.wddty.com/magazine/2018/september/poisoned-in-slow-motion.html

"Over the past decades, a wealth of information has been reported about the pathogenic features of immune thrombocytopenia (ITP). To this day, however, it is unclear whether the immune abnormalities associated with ITP play causative roles in the disease or are secondary epiphenomena brought on by the inflammatory processes that are associated with the disorder. Like the majority of all autoimmune diseases, ITP is an organ‐specific disease and abnormalities in immune cell types, such as antigen‐presenting cells (APC), T cells and B cells have been shown to play some sort of role in the initiation and/or perpetuation of the disease. This review will discuss recent advances in understanding three immune cells important in ITP pathophysiology: APC, T cells and B cells, and will review how they interact with each other to initiate and perpetuate ITP, particularly the chronic form of the disorder. It will also focus on new data related to the genetics of the disorder and discuss relevant animal models of ITP."
See more.......

onlinelibrary.wiley.com/doi/full/10.1111/bjh.12480

Here are links to back it up:

"Thimerosal is an organic-mercury (Hg) based compound, used as a preservative in many childhood vaccines, in the past and present. To date, there have been over 165 studies that focused on Thimerosal and found it to be harmful [1, 2]. (A comprehensive list of these studies is shown at mercury-freedrugs.org/docs/20140329_Kern_JK_ExcelFile_TM_sHarm_ReferenceList_v33.xlsx.) Of these studies, 16 were conducted to specifically examine the effects of Thimerosal on human infants and/or children [3–18]. Within these studies, which focused on human infants and/or children, the reported outcomes following Thimerosal exposure were (1) death [3]; (2) acrodynia [4]; (3) poisoning [5]; (4) allergic reaction [6]; (5) malformations [7]; (6) autoimmune reaction [8]; (7) Well's syndrome [9]; (8) developmental delay [10–13]; and (9) neurodevelopmental disorders, including tics, speech delay, language delay, attention deficit disorder, and autism.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4065774/

"Over the last 200 years, mining, smelting, and refining of aluminum (Al) in various forms have increasingly exposed living species to this naturally abundant metal. Because of its prevalence in the earth's crust, prior to its recent uses it was regarded as inert and therefore harmless. However, Al is invariably toxic to living systems and has no known beneficial role in any biological systems. Humans are increasingly exposed to Al from food, water, medicinals, vaccines, and cosmetics, as well as from industrial occupational exposure. Al disrupts biological self-ordering, energy transduction, and signaling systems, thus increasing biosemiotic entropy. Beginning with the biophysics of water, disruption progresses through the macromolecules that are crucial to living processes (DNAs, RNAs, proteoglycans, and proteins). It injures cells, circuits, and subsystems and can cause catastrophic failures ending in death. Al forms toxic complexes with other elements, such as fluorine, and interacts negatively with mercury, lead, and glyphosate. Al negatively impacts the central nervous system in all species that have been studied, including humans. Because of the global impacts of Al on water dynamics and biosemiotic systems, CNS disorders in humans are sensitive indicators of the Al toxicants to which we are being exposed."

www.ncbi.nlm.nih.gov/pmc/articles/PMC4202242/

"Autoimmune diseases, including multiple sclerosis and type 1 diabetes mellitus, affect about 5% of the worldwide population. In the last decade, reports have accumulated on various autoimmune disorders, such as idiopathic thrombocytopenia purpura, myopericarditis, primary ovarian failure, and systemic lupus erythematosus (SLE), following vaccination. In this review, we discuss the possible underlying mechanisms of autoimmune reactions following vaccinations and review cases of autoimmune diseases that have been correlated with vaccination. Molecular mimicry and bystander activation are reported as possible mechanisms by which vaccines can cause autoimmune reactions. The individuals who might be susceptible to develop these reactions could be especially not only those with previous post-vaccination phenomena and those with allergies but also in individuals who are prone to develop autoimmune diseases, such as those with a family history of autoimmunity or with known autoantibodies, and the genetic predisposed individuals."

www.ncbi.nlm.nih.gov/pmc/articles/PMC5607155/

"The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) is a recently identified condition in which the exposure to an adjuvant leads to an aberrant autoimmune response. We aimed to summarize the results obtained from the ASIA syndrome registry up to December 2016, in a descriptive analysis of 300 cases of ASIA syndrome, with a focus on the adjuvants, the clinical manifestations, and the relationship with other autoimmune diseases. A Web-based registry, based on a multicenter international study, collected clinical and laboratory data in a form of a questionnaire applied to patients with ASIA syndrome. Experts in the disease validated all cases independently. A comparison study regarding type of adjuvants and differences in clinical and laboratory findings was performed. Three hundred patients were analyzed. The mean age at disease onset was 37 years, and the mean duration of time latency between adjuvant stimuli and development of autoimmune conditions was 16.8 months, ranging between 3 days to 5 years. Arthralgia, myalgia, and chronic fatigue were the most frequently reported symptoms. Eighty-nine percent of patients were also diagnosed with another defined rheumatic/autoimmune condition. The most frequent autoimmune disease related to ASIA syndrome was undifferentiated connective tissue disease (UCTD). ASIA syndrome is associated with a high incidence of UCTD and positive anti-nuclear antibodies (ANA) test. Clinical and laboratory features differ from the type of adjuvant used. These findings may contribute to an increased awareness of ASIA syndrome and help physicians to identify patients at a greater risk of autoimmune diseases following the exposure to vaccines and other adjuvants. The ASIA syndrome registry provides a useful tool to systematize this rare condition."

www.ncbi.nlm.nih.gov/pubmed/28741088

Recipe for Fostering Public Interest and High Vaccine Demand
www.nationalacademies.org/hmd/~/media/E9B963EDB28645C5ABCC22467120662D.ashx

"David Tian, 24, a first-year Harvard Medical student, said: “Before coming here (Harvard), I had no idea how much influence companies had on medical education. And it’s something that’s purposely meant to be under the table, providing information under the guise of education when that information is also presented for marketing purposes.”

www.nytimes.com/2009/03/03/business/03medschool.html?smid=fb-share

"Full efficacy data for the 2017-2018 flu season are still being compiled, but pEpitope has predicted it will be around 19 percent against H3N2, the type of influenza A that infected most people in the U.S. in each of the past two years. The Food and Drug Administration chose the same vaccine formulation in 2017 and 2016, in part because the dominant circulating strain stayed the same. In 2016, the vaccine had an efficacy of 20 percent, almost identical to the efficacy of 19 percent predicted by pEpitope.
Efficacy is the measure of how effective a vaccine is at protecting the overall population. A 20 percent efficacy means that in a population, 20 percent fewer vaccinated people will get the flu compared to the unvaccinated people."

www.sciencedaily.com/releases/2018/04/180419131015.htm

"The results of this review seem to discourage the utilisation of vaccination against influenza in healthy adults as a routine public health measure.
As healthy adults have a low risk of complications due to respiratory disease, the use of the vaccine may be only advised as an individual protection measure against symptoms in specific cases.”

ahrp.org/cochrane-collaboration-flu-vaccines-of-no-benefit/

"Since the implementation of the mass vaccination campaign against hepatitis B in France, the appearance of multiple sclerosis, sometimes occurring in the aftermath of vaccinations, led to the publication of epidemiological international studies. This was also justified by the sharp increase in the annual incidence of multiple sclerosis reported to the French health insurance in the mid-1990s. Almost 20 years later, a retrospective reflection can be sketched from these official data and also from the national pharmacovigilance agency. Statistical data from these latter sources seem to show a significant correlation between the number of hepatitis B vaccinations performed and the declaration to the pharmacovigilance of multiple sclerosis occurring between 1 and 2 years later. The application of the Hill’s criteria to these data indicates that the correlation between hepatitis B vaccine and multiple sclerosis may be causal."

www.ncbi.nlm.nih.gov/pmc/articles/PMC4065774/

"Vaccinations have been used as an essential tool in the fight against infectious diseases, and succeeded in improving public health. However, adverse effects, including autoimmune conditions may occur following vaccinations (autoimmune/inflammatory syndrome induced by adjuvants--ASIA syndrome). It has been postulated that autoimmunity could be triggered or enhanced by the vaccine immunogen contents, as well as by adjuvants, which are used to increase the immune reaction to the immunogen. Fortunately, vaccination-related ASIA is uncommon. Yet, by defining individuals at risk we may further limit the number of individuals developing post-vaccination ASIA. In this perspective we defined four groups of individuals who might be susceptible to develop vaccination-induced ASIA: patients with prior post-vaccination autoimmune phenomena, patients with a medical history of autoimmunity, patients with a history of allergic reactions, and individuals who are prone to develop autoimmunity (having a family history of autoimmune diseases; asymptomatic carriers of autoantibodies; carrying certain genetic profiles, etc.)."

www.ncbi.nlm.nih.gov/pubmed/25277820/

"A number of previous studies have suggested that flu shots could reduce the number of community-living elderly people who die in winter by as much as 50%, according to the report by Lone Simonsen, PhD, of the National Institutes of Health (NIH), and colleagues from NIH and other organizations.

But the authors say they could find no evidence that increasing flu vaccination coverage among people 65 and older lowered mortality rates. Further, they concluded that the number of flu-related deaths in the elderly from 1968 through 2001 was never more than 10% of all winter deaths, suggesting that flu immunization could have only a relatively small effect on total death rates.

"We conclude . . . that there are not enough influenza-related deaths to support the conclusion that vaccination can reduce total winter mortality among the US elderly population by as much as half," states the article, published yesterday in Archives of Internal Medicine."

www.cidrap.umn.edu/news-perspective/2005/02/study-flu-shots-elderly-dont-cut-mortality-rate

"US data on influenza deaths are a mess. The Centers for Disease Control and Prevention (CDC) acknowledges a difference between flu death and flu associated death yet uses the terms interchangeably. Additionally, there are significant statistical incompatibilities between official estimates and national vital statistics data. Compounding these problems is a marketing of fear—a CDC communications strategy in which medical experts “predict dire outcomes” during flu seasons."

www.ncbi.nlm.nih.gov/pmc/articles/PMC1309667/

"The ACIP policy recommendation of routinely administering influenza vaccine during pregnancy is ill-advised and unsupported
by current scientific literature, and it should be withdrawn. Use of thimerosal during pregnancy should be contraindicated."

thinktwice.com/Influenza_vaccination_during_pregnancy_Ayoub_Yazbak.pdf

One vaccine insert:

Blood and Lymphatic System Disorders
Lymphadenopathy.
Cardiac Disorders
Tachycardia.
Ear and Labyrinth Disorders
Vertigo.
Eye Disorders
Conjunctivitis, eye irritation, eye pain, eye redness, eye swelling, eyelid swelling.
Gastrointestinal Disorders
Abdominal pain or discomfort,
swelling of the mouth, throat, and/or tongue.
General Disorders and Administration Site Conditions
Asthenia, chest pain, influenza-like illness, feeling hot, injection site mass, injection site reaction,
injection site warmth, body aches
.Immune System Disorders
Anaphylactic reaction including shock, anaphylactoid reaction, hypersensitivity, serum sickness.
Infections and Infestations
Injection site abscess, injection site cellulitis, pharyngitis, rhinitis, tonsillitisNervous System Disorders
Convulsion, encephalomyelitis, facial palsy, facial paresis, Guillain-Barré syndrome, hypoesthesia,
myelitis, neuritis, neuropathy, paresthesia, syncope.
Respiratory, Thoracic ,and Mediastinal Disorders
Asthma, bronchospasm, dyspnea, respiratory distress, stridor.
Skin and Subcutaneous Tissue Disorders
Angioedema, erythema, erythema multiforme, facial swelling, pruritus, Stevens-Johnson syndrome, sweating,
urticaria.
Vascular Disorders
Henoch-Schönlein purpura, vasculitis
www.gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Fluarix_Quadrivalent/pdf/FLUARIX-QUADRIVALENT.PDF

Another insert:

Blood and Lymphatic System Disorders:
Thrombocytopenia, lymphadenopathy
Immune System Disorders:
Anaphylaxis, other allergic/hypersensitivity reactions (including urticaria, angioedema)
Eye Disorders:
Ocular hyperemia
Nervous System Disorders:
Guillain-Barré syndrome (GBS), convulsions, febrile convulsions, myelitis (including encephalomyelitis and transverse myelitis), facial palsy (Bell’s palsy), optic neuritis/neuropathy, brachial neuritis, syncope (shortly after vaccination), dizziness, paresthesia
Vascular Disorders:
Vasculitis, vasodilatation/flushing
Respiratory, Thoracic and Mediastinal Disorders:
Dyspnea, pharyngitis, rhinitis, cough, wheezing, throat tightness
Skin and Subcutaneous Tissue Disorders:
Stevens-Johnson syndrom
General Disorders and Administration Site Conditions:
Pruritus, asthenia/fatigue, pain in extremities, chest pain
Gastrointestinal Disorders:
Vomiting, Nausea, diarrhea
General Disorders and Administration Site Conditions:
Chills
www.vaccineshoppe.com/image.cfm?pi=fluHD&image_type=product_pdf

I have many more studies.

"The vaccination might display autoimmune side effects and potentially even trigger a full-blown autoimmune disease. This susceptibility to vaccine-induced autoimmunity is probably determined also by genetic predisposition, which further emphasizes the importance of “the mosaic of autoimmunity” [4]. The vaccination decreases the morbidity and mortality of the individuals, especially children. Nevertheless, the dilemma of whom and when to vaccinate remains unresolved and further research is needed to explain the action mechanism."

www.ncbi.nlm.nih.gov/pmc/articles/PMC5607155/

"Since the early 1800s vaccines have saved numerous lives by preventing lethal infections. However, during the past two decades, there has been growing awareness of possible adverse events associated with vaccinations, cultivating heated debates and leading to significant fluctuations in vaccination rates. It is therefore pertinent for the scientific community to seriously address public concern of adverse effects of vaccines to regain public trust in these important medical interventions. Such adverse reactions to vaccines may be viewed as a result of the interaction between susceptibility of the vaccinated subject and various vaccine components. Among the implicated mechanisms for these reactions is molecular mimicry. Molecular mimicry refers to a significant similarity between certain pathogenic elements contained in the vaccine and specific human proteins. This similarity may lead to immune crossreactivity, wherein the reaction of the immune system towards the pathogenic antigens may harm the similar human proteins, essentially causing autoimmune disease. In this review, we address the concept of molecular mimicry and its application in explaining post vaccination autoimmune phenomena. We further review the principal examples of the influenza, hepatitis B, and human papilloma virus vaccines, all suspected to induce autoimmunity via molecular mimicry. Finally, we refer to possible implications on the potential future development of better, safer vaccines."

www.ncbi.nlm.nih.gov/pubmed/29503439

"Background

The introduction of modified live viruses as vaccines enable the virus to attach its genetic material into the cell which replicates i.e. the host cell continues to function whilst producing the viral protein. This stimulates the production of antibodies. Under normal circumstances exposure to a viral disease would be countered (in vivo) at various levels enabling the body to steadily increase its immune response. By contrast, the injection of vaccines directly into the blood system overpowers the normal immune response leading to its rapid depletion. It is now suspected that long-term persistence of viruses and other proteins may produce chronic disease i.e. instead of producing a genuine immunity the vaccines are altering the body's systemic and biochemical stability, suppressing the production of differing types of white blood cells and hence immune function. Furthermore the introduction of many vaccines (up to 30 in a typical vaccination schedule) introduces a large number of foreign proteins which may be sufficient to ensure that immune function never returns to baseline and/or that immune biochemistry is fundamentally altered[62]. Consequently there now exists a growing concern which links immunizations to the huge increase in recent decades of auto-immune diseases[79] e.g., rheumatoid arthritis[80,81], multiple sclerosis, lupus erythematosus, lymphoma, leukemia, autoimmune demyelinative optic neuritis, diabetes mellitus, etc."

www.ncbi.nlm.nih.gov/pmc/articles/PMC3364648/?fbclid=IwAR0SKjwd6BTSFxPdnzQFok4ki0ofTE8AZvPuzZj6I311RGfwMwhZa2wm6z4#!po=26.9444

I hope you guys at least take a look at this one. You are literally trusting these people with your lives. This is a video clip of the ACIP approval for a new Hepatitis B vaccine, a letter from a Cardiologist who was on the approval committee, and the actual clinical trial briefing document. This new vaccine was denied approval by the FDA twice because 14 people (out of 5,600) in the trial died of heart attacks. They approved it the third time it was submitted. The bottom line is that even though 14 people died, they are going to rely on post-marketing experience to see if heart attacks are, indeed, a problem with this new vaccine. We are the test subjects with this Hep B vaccine and Shingrix (which is also new and has no post-marketing experience). Both are using brand new, highly inflammatory adjuvants. You are not receiving informed consent which is your inherent right as a patient. Doctors assume that because the vaccine is on the market, it must be safe for the public. This information proves that it's not! You are part of the post-marketing clinical trial whether you know it or not.

I just read a FB post today...a woman was asking for information because her mother died of a sudden heart attack. Two days earlier she'd had the new Hep B vaccine and a flu shot. She needed them for a new job she would have started in a few days.

www.youtube.com/watch?v=7UzQqan3uF8

www.medpagetoday.com/Blogs/RevolutionandRevelation/67019

www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM568489.pdf

Thank you so much for posting this Sandy. I have been researching a lot too since I developed ITP and agree with you. I wish I knew better about vaccines. My kiddo got very ill after a vaccine.

The schedule needs to spread out and all those harmful chemicals removed from the vaccines.

Sandi wrote:

Abstract
BACKGROUND:

The presence of SV40 in monkey cell cultures used in the preparation of the polio vaccine from 1955 through 1961 is well documented. Investigations have consistently demonstrated the oncogenic behavior of SV40 in animal models. Early epidemiologic studies were inadequate in demonstrating an increase in cancer incidence associated with contaminated vaccine. Recently, investigators have provided persuasive evidence that SV40 is present in human ependymomas, choroid plexus tumors, bone tumors, and mesotheliomas, however, the etiologic role of the virus in tumorigenesis has not been established.

MATERIALS AND METHODS:

Using data from SEER, we analyzed the incidence of brain tumors, bone tumors, and mesotheliomas from 1973-1993 and the possible relationship of these tumors with the administration of the SV40 contaminated vaccine.

RESULTS:

Our analysis indicates increased rates of ependymomas (37%), osteogenic sarcomas (26%), other bone tumors (34%) and mesothelioma (90%) among those in the exposed as compared to the unexposed birth cohort.
CONCLUSIONS:

These data suggest that there may be an increased incidence of certain cancers among the 98 million persons exposed to contaminated polio vaccine in the U.S.; further investigations are clearly justified.

www.ncbi.nlm.nih.gov/pubmed/10472327


Abstract
BACKGROUND:

Adverse events following immunization (AEFI) requires special consideration in patients with primary immunodeficiency diseases (PID) because they may represent a "red flag" for the initial diagnosis and may cause disease complications. Therefore, the definition of appropriate vaccination schemes is a major issue in PID. The aim of this study is to describe the AEFI in a cohort of PID patients.

METHODS:

Medical records from 379 PID patients were included. AEFI severity was classified according to the WHO 1999 guidelines. Causality was assessed using the Clinical Immunization Safety Assessment (CISA) 2009 criteria.

RESULTS:

Evidence of AEFI was found in 26 medical records and represented a total of 29 reactions. Most of the AEFI were observed in patients with idiopathic hypogammaglobulinemia (IHG), chronic granulomatous disease (CGD) and severe combined immunodeficiency (SCID), representing 10, 4 and 4 cases, respectively. A total of 21 reactions were associated with replicative vaccines, 7 of which were serious cases related to Bacille Calmette-Guérin (BCG). BCG was also the vaccine more often associated with definitive AEFI in PID. In addition to BCG-related complications, seizures were the most serious AEFI among PID patients.

CONCLUSIONS:

Our study included a large cohort of PID patients and confirmed an increased risk of serious AEFI in these populations. The design and implementation of neonatal screening strategies for the early detection of congenital lymphopenias and other PID are urgently needed to avoid serious complications of the BCG vaccine usually applied immediately after birth. Our findings also support the use of the acellular pertussis vaccine to minimize the appearance of seizures in PID patients vaccinated with diphtheria, pertussis and tetanus (DPT).

Copyright © 2016. Published by Elsevier Ltd.

www.ncbi.nlm.nih.gov/pubmed/26850760


Thimerosal, which contains the organic compound ethyl mercury, is a known neurotoxin and used to be a major ingredient in childhood vaccines. There are over 15,000 articles in the medical literature describing the adverse health effects on the human body with exposure to varying amounts and forms of mercury.

In 1999 the American Academy of Pediatrics (AAP) urged government agencies to work rapidly toward reducing children's exposure to mercury from all sources. Because any potential risk was of concern, the AAP and the USPHS (United States Public Health Service) agreed that the use of thimerosal-containing vaccines should be reduced or eliminated.[1] The AAP recommended that it would be a good idea to remove thimerosal from vaccines, even though according to them, there was no evidence linking childhood health issues to thimerosal exposure from vaccines. In 2008, children are still being injected with thimerosal-containing vaccines, and old stocks of thimerosal-containing vaccines manufactured by 1999 continued to be administered to children up to 2003.

However, a growing number of physicians, scientists and parents maintain that thimerosal has played, and continues to play a large role in contributing to the emergence of multiple chronic illnesses in children and adults, including the neurological spectrum disorders. Aluminum, which is present in the environment and in many childhood vaccines, may be affecting the health of our children in ways that we have yet to understand.

Aluminum is a heavy metal with known neurotoxic effects on human and animal nervous systems. It can be found in the following childhood vaccines – DTaP, Pediarix (DTaP-Hepatitis B-Polio combination), Pentacel (DTaP-HIB-Polio combination), Hepatitis A, Hepatitis B, Haemophilus influenzae B (HIB), Human Papilloma Virus (HPV), and Pneumococcal vaccines.[2]

In 1996, the American Academy of Pediatrics issued a position paper on Aluminum Toxicity in Infants and Children which stated in the first paragraph, “Aluminum is now being implicated as interfering with a variety of cellular and metabolic processes in the nervous system and in other tissues.

More......

www.nvic.org/Doctors-Corner/Aluminum-and-Vaccine-Ingredients.aspx

Even the FDA thinks so. This is on their page.

"Virus-based vaccines are made in living cells (cell substrates). Some manufacturers are investigating the use of new cell lines to make vaccines. The continual growth of cell lines ensures that there is a consistent supply of the same cells that can yield high quantities of the vaccine.

In some cases the cell lines that are used might be tumorigenic, that is, they form tumors when injected into rodents. Some of these tumor-forming cell lines may contain cancer-causing viruses that are not actively reproducing. Such viruses are hard to detect using standard methods. These latent, or "quiet," viruses pose a potential threat, since they might become active under vaccine manufacturing conditions. Therefore, to ensure the safety of vaccines, our laboratory is investigating ways to activate latent viruses in cell lines and to detect the activated viruses, as well as other unknown viruses, using new technologies. We will then adapt our findings to detect viruses in the same types of cell substrates that are used to produce vaccines. We are also trying to identify specific biological processes that reflect virus activity.

These methods will enable FDA scientists to help manufacturers to determine whether their specific cell substrate is safe to use for vaccine production. The methods our laboratory are developing and testing will help to ensure the production of safe and effective vaccines in two ways: 1) FDA will be able to develop testing guidelines for manufacturers who use new cell substrates for producing vaccines; and 2) FDA will publish the new methods it develops in peer-reviewed scientific journals, thus making them readily accessible to all manufacturers.

We are also evaluating the risk of retrovirus infections in humans. (Retroviruses are RNA viruses that use an enzyme called reverse transcriptase (RT) to replicate; RNA is the de-coded form of DNA). Simian foamy virus (SFV) can be transmitted from nonhuman primates (e.g., monkeys) to humans. Although there is no evidence that SFV causes disease, the virus can remain in a lifelong quiet state in the DNA after infection. Moreover, two individuals in Africa were recently found to be infected with both HIV-1 and SFV. Therefore, it is important to determine if SFV poses a threat to human health and to understand how the virus spreads in order to create strategies for controlling human infections. Such work will also help FDA to develop a new policy regarding blood donation by individuals working with nonhuman primates and implementing formal safety guidelines for people working with SFV-infected animals. We are also investigating the consequences of dual SFV and HIV-1 infection in the monkey model."

www.fda.gov/biologicsbloodvaccines/scienceresearch/biologicsresearchareas/ucm127327.htm?fbclid=IwAR2yeOuCgQ5XKI0RT7Yk6jHauSJmXvdr5yj-neM3Iqyjb7b6hBVSD4Y0Y0w